Kura Oncology Ownership | Who Owns Kura Oncology?
Kura Oncology Ownership Summary
Kura Oncology is owned by 93.79% institutional investors, 1.15% insiders, and 5.07% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.81% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.10% of its assets in Kura Oncology shares.
KURA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Kura Oncology | 93.79% | 1.15% | 5.07% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 9.47M | 10.81% | $54.64M |
Suvretta capital management | 8.12M | 9.27% | $46.83M |
Bvf inc/il | 7.75M | 8.85% | $44.74M |
Blackrock | 6.97M | 8.30% | $143.43M |
Armistice capital | 6.20M | 7.08% | $35.77M |
Vanguard group | 4.82M | 5.54% | $41.97M |
Ecor1 capital | 3.56M | 4.09% | $30.98M |
Prosight management, lp | 3.18M | 3.63% | $18.36M |
State street | 2.88M | 3.44% | $59.39M |
Millennium management | 2.37M | 2.72% | $20.62M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Prosight management, lp | 3.18M | 4.48% | $18.36M |
Alethea capital management | 558.44K | 4.16% | $4.86M |
Foresite capital management iv | 816.88K | 3.81% | $4.71M |
Bvf inc/il | 7.75M | 1.60% | $44.74M |
Suvretta capital management | 8.12M | 1.41% | $46.83M |
Sectoral asset management | 323.57K | 1.23% | $1.87M |
Ecor1 capital | 3.56M | 1.17% | $30.98M |
1492 capital management | 423.95K | 1.13% | $2.45M |
Boxer capital | 1.00M | 1.08% | $20.59M |
Artal group | 1.82M | 0.96% | $37.47M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 2.37M | 0.01% | 1.52M |
Blackrock funding, inc. /de | 9.47M | 0.00% | 1.29M |
Prosight management, lp | 3.18M | 4.48% | 1.10M |
Qube research | 1.91M | 0.01% | 738.76K |
D. e. shaw | 1.15M | 0.01% | 727.99K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deerfield management company, l.p. (series c) | - | - | -5.41M |
Paradigm biocapital advisors lp | - | - | -4.33M |
Ra capital management | - | - | -4.00M |
Avoro capital advisors | - | - | -2.25M |
Ecor1 capital | 3.56M | 1.17% | -2.25M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Sectoral asset management | 323.57K | 1.23% | 323.57K | $1.87M |
Apis capital advisors | 180.00K | 0.37% | 180.00K | $1.04M |
Gsa capital partners llp | 89.31K | 0.06% | 89.31K | $778.00K |
Los angeles capital management | 77.96K | 0.00% | 77.96K | $449.82K |
Alps advisors | 46.66K | 0.00% | 46.66K | $269.23K |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -1.00 |
Ifp advisors | -9.00 |
Quantbot technologies lp | -14.00 |
Nelson, van denburg & campbell wealth management group | -14.00 |
Smartleaf asset management | -17.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 183 | -2.14% | 82,143,917 | 5.53% | 93 | 1.18% | 112 | 16.67% | 43 | -24.56% |
Mar 31, 2025 | 187 | -1.06% | 80,458,625 | 1.94% | 92 | 1.12% | 97 | -19.83% | 57 | 62.86% |
Dec 31, 2024 | 104 | -43.48% | 28,722,448 | -65.13% | 33 | 0.37% | 68 | -17.07% | 14 | -75.00% |
Sep 30, 2024 | 183 | 2.23% | 82,304,529 | 2.31% | 94 | 1.03% | 82 | -2.38% | 56 | -9.68% |
Jun 30, 2024 | 179 | 4.68% | 80,450,005 | -0.33% | 95 | 1.04% | 84 | -11.58% | 62 | 31.91% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.69M | 3.10% | -59.74K |
Vanguard US Total Market Shares ETF | 2.17M | 2.68% | 3.54K |
iShares Russell 2000 ETF | 1.85M | 2.13% | -35.07K |
SPDR® S&P Biotech ETF | 1.27M | 1.47% | 31.46K |
HBM Healthcare Investments AG Ord | 1.21M | 1.40% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 974.31K | 1.12% | -440.17K |
Invesco MSCI World ETF | 897.58K | 1.03% | 897.58K |
BlackRock Advantage Small Cap Core Instl | 769.61K | 0.89% | 125.68K |
Fidelity Small Cap Index | 748.20K | 0.86% | -11.97K |
iShares Russell 2000 Value ETF | 699.17K | 0.81% | 17.81K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 08, 2025 | WILSON TROY EDWARD | President & CEO | Buy | $410.14K |
Aug 13, 2025 | WILSON TROY EDWARD | President and CEO | Buy | $89.62K |
Aug 12, 2025 | WILSON TROY EDWARD | President and CEO | Buy | $213.58K |
May 19, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | $9.29K |
May 19, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | $9.78K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | 3 | - |
2025 Q2 | - | 2 |
2025 Q1 | - | 15 |
2024 Q4 | - | 1 |
2024 Q3 | - | - |
KURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools